glp-1 drugs pharmaceutical companies partnerships 2025 Market Size to Hit USD 212.73 Billion by 2035 GLP-1 Drugs Show Potential To
Description
[DOI] [PubMed] [Google Scholar] [103].A Study for Patients With Type 2 Diabetes Mellitus
Step therapy is common
These drugs, derived from the hormone glucagon-like peptide-1, enhance insulin secretion, delay gastric emptying, reduce appetite, and promote weight loss [6]
government data shows, and around 12% say they currently take GLP-1 drugs, according to a poll published last month by health policy research organization KFF
